This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

At RSNA ’13, Siemens Offers Answers For Life

Stocks in this article: SI

At the 99 th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), December 1 to 6 in Chicago, Siemens Healthcare (Booth #1934, South Building/Lakeside Center at McCormick Place, Hall A) will provide “Answers for Life” by offering cutting-edge and accessible technological innovations designed to advance human health. With these systems and related solutions, Siemens will demonstrate its enduring status as a trusted partner that helps its customers fight the world’s most threatening diseases, elevate quality and productivity in health care, and enable improved access to treatment.

At RSNA 2013, Siemens will showcase the following innovations:

Angiography

The visionary Artis Q and Artis Q.zen angiography systems from Siemens feature a revolutionary X-ray tube and detector technology designed to improve minimally invasive therapy for coronary artery disease (CAD), stroke and cancer, helping hospitals improve patient outcomes and satisfaction. The Artis Q.zen product line combines the X-ray tube with a new crystalline silicon detector that permits imaging at ultra-low radiation levels, enabling utilization of doses as low as half the standard levels applied in angiography. Paired with CARE+CLEAR, a comprehensive portfolio of image quality and dose-saving tools that is standard with all Artis systems, Siemens is determined to provide the lowest possible dose to its customers. Its innovative technology, backed by the value it generates at various levels of the care continuum, has been recognized by Frost & Sullivan with the 2013 North American Award for Company of the Year.

Computed Tomography

Engineered to drive efficiency and reduce costs, the new 16- and 32-slice configurations of Siemens’ SOMATOM Perspective family of computed tomography (CT) scanners 1 bring high-end technologies to a broader clientele, with the option of upgrading to the established 64- and 128-slice configurations. In addition to being suitable for routine oncology scans as well as head, neck, lung, and abdominal imaging, the 16-slice SOMATOM Perspective can help ensure that pain-relieving analgesics are delivered to the correct location during surgery. The 32-slice configuration is designed to provide more detailed imaging for bone fractures, inner ear examinations, and vascular applications. Both configurations of the SOMATOM Perspective feature the SAFIRE (Sinogram Affirmed Iterative Reconstruction) 2 algorithm, which enables the user to reduce radiation dose by as much as 60 percent or improve image quality correspondingly.

Magnetic Resonance

At RSNA 2013, Siemens will debut revolutionary technologies designed to enable fast body magnetic resonance (MR) imaging for all patients. The technologies will be available on the MAGNETOM Skyra 3T and MAGNETOM Area 1.5T MRI systems. The new StarVIBE MR pulse sequence is designed to enable free-breathing, contrast-enhanced liver imaging for patients (including patients who are old, very ill, or young) unable to easily manage breath-holding. Siemens’ new TWIST-VIBE MR sequence is designed to enable correct contrast imaging in dynamic liver MRI for all patients and lesions, allowing fast, robust liver imaging with full 4D coverage. The sequences StarVIBE and TWIST-VIBE will be available as the FREEZEit package.

1 of 4

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs